Medical Cannabis

In this month’s webinar, Dustin Sulak, DO, summarizes and provides insights on cannabis studies for chronic pain, restless leg syndrome, insomnia, effects on driving, and more.

As Texas advances legislation to ban hemp-derived THC, HB 46 seeks to expand the state’s medical cannabis program, with several recent changes.

Researchers analyzed data from 262 counties, identifying sociodemographic characterizations, associations, and discrepancies.

Curaleaf International and Jupiter Research LLC, announce the first liquid inhalation device has received an EU medical device certification.

Recently introduced legislation in Maine focuses on testing and safety for medical cannabis in the state.

Here, we bring you our top five recent articles covering a cannabis advertising ban in Mississippi, reforms urged in Canada, the latest Healer webinar, a study on THC and driving skills, and intoxicating hemp product sales in Ohio.

The large-scale analysis focused on the language of the studies to establish positive, negative, or neutral associations with cannabis and cancer.

The latest webinar covered five studies on cannabis for various conditions including hypermobility, eczema, Parkinson’s disease, and other conditions.

Patients in Australia with chronic health conditions evaluated the effects on their quality of life, changes in pain, and more after 12 months of medical cannabis.

Here, we bring you our top four recent articles covering standards in the cannabis industry, a cannabis for sleep survey, a new research and resource center at the University of Mississippi, and in-person information sessions from Metrc.

The survey included responses from over one thousand medical cannabis patients, plus an analysis of trends in the medical cannabis market.

This month’s Healer webinar explored how recent cannabis policies impact patients, parents, and more.

Industry feedback is being considered in developing pathways to make CBD accessible – and safe – to treat minor health conditions without a prescription.

Webinar Date/Time: Thu, Mar 20, 2025 10:00 AM EDT

Here, we bring you our top four recent news articles covering research for cannabis and ALS and autism, updates from the NCIA, and testing license applications in Alabama.

This webinar covered how cannabis for this neurodegenerative disease could provide better symptom relief and improve quality of life better than conventional treatments.

The Alabama Medical Cannabis Commission made the announcement in its most recent meeting, intending to advance the state medical cannabis program.

The company removed the eligibility barrier for medical cannabis patients in Australia to access certain products.

This recently published study examined the effects of personalized coaching on the use of medical cannabis for chronic pain.

This webinar discussed recent research on medical cannabis for conditions such as alcohol use disorder and chronic pain, directed for attendees of all backgrounds.

In this research overview, Ruth Fisher, PhD, explores how cannabis has shown promise in helping individuals reduce opioid use, potentially decreasing overdose deaths. Though its impact on chronic pain and opioid reduction remains evident, limitations exist and flaws in methodologies in ecological studies complicate conclusions.

The partnership aims to support research, education, and patient access, aligning with both companies’ missions.

Here, we bring you our top five recent news articles, covering delays in the cannabis rescheduling hearings, DoorDash’s expansion into hemp-derived products, and more.

The internship will provide hands-on experience in medical cannabis cultivation in the country’s expanding medical cannabis market.

In response to the recent announcement that the hearing concerning cannabis rescheduling had been delayed, Americans for Safe Access held a webinar discussing the impacts medical cannabis.